What’s new in genetics?


Dark side of precision medicine:

A report from the Mayo Clinic highlights one fear as precision medicine continues to expand, that the quality of databases used to interpret genetic information are not up to date. The report includes several cases in which patients were treated based on a genetic mutation that was believed to be disease causing. A later reanalysis revealed the mutation did not cause the heart condition the patients were concerned about. How will we prevent misdiagnoses and potentially harmful treatment via precision medicine?

Should we sequence the genes of our newborns?

The BabySeq project funded by the NIH aims to understand how sequencing newborns will affect the children and families involved. Researchers hope to investigate whether having more information about what lies in a baby’s genes will lead to higher health care costs. You can read how some families responded to the option and results of sequencing, here.    

Onward to a synthetic genome:

The scientists behind Genome Project-Write, the project to create an entire genome from scratch, have released a draft timeline of how they expect the research to progress. The team of researchers has yet to decide which genomes to focus their efforts on and are currently seeking proposals for pilot projects to begin this effort.

Thanks for reading!


About Author

Stephany Foster

Stephany Foster is the Associate Scientific Writer at Recombine, a genetic testing company based in New York City. She writes on topics spanning fertility, reproductive medicine, and recent advances in genomics. Stephany also writes about recently published research that Recombine presents at conferences and meetings around the globe. Before joining Recombine, Stephany interned at the George Church Lab at Harvard Medical School. She graduated from Brown University with an A.B. in Biology in 2014.